2.85
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché SONN Giù?
Forum
Previsione
Frazionamento azionario
Sonnet Biotherapeutics Holdings Inc Azioni (SONN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
100.00%
-
|
1.00 | - | - | - |
|
9.87%
4.2294
|
3.8494 | 3.1734 | 3.5287 | 3.8686 |
Benefits Costs and Expenses |
12.77%
3.4911
|
4.0023 | -4.3273 | 3.5056 | 0.8217 |
Costs And Expenses |
1.85%
4.0765
|
4.0023 | 3.1734 | 3.5287 | 3.8686 |
Operating Income/Loss |
48.43%
-4.2294
|
-2.8494 | -3.1734 | -3.5287 | -3.8686 |
Income/Loss From Continuing Operations Before Tax |
16.28%
-3.4911
|
-3.0023 | 4.3273 | -3.5056 | 0.3654 |
Income/Loss From Continuing Operations After Tax |
10.45%
-3.4911
|
-3.1607 | -3.1286 | -3.5056 | 0.3654 |
|
10.45%
-3.4911
|
-3.1607 | -3.1286 | -3.5056 | 0.3654 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
93.87%
3.9216
|
2.0228 | -3.8266 | 5.0375 | 4.6177 |
Diluted Average Shares |
93.87%
3.9216
|
2.0228 | -3.8266 | 5.0375 | 4.8858 |
Basic Earnings Per Share |
42.95%
-0.89
|
-1.56 | -10.39 | -0.70 | 0.08 |
Diluted Earnings Per Share |
42.95%
-0.89
|
-1.56 | -10.39 | -0.70 | 0.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):